Home > Boards > Free Zone > Health and Sciences > Biotech Values

(MNTA)—TEVA drops Copaxone lawsuit against MYL on ‘775

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 722
Posts 109,264
Boards Moderated 12
Alias Born 09/05/02
160x600 placeholder
DewDiligence Member Level  Monday, 12/11/17 06:45:51 PM
Re: Bickema post# 214086
Post # of 226390 
(MNTA)—TEVA drops Copaxone lawsuit against MYL on ‘775 and ‘993 (non-Orange-Book) manufacturing patents after US District Court sides with MYL in Markman hearing:

https://www.prnewswire.com/news-releases/teva-dismisses-litigation-after-mylan-wins-us-court-ruling-related-to-tevas-cold-filtration-patents-for-copaxone-40-mgml-300569596.html

According to the CEO, MNTA designed around TEVA’s Copaxone-manufacturing patents and hence was never at risk from the lawsuit in question.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist